About this Research Topic
This Research Topic focuses on the impact of these complex regulatory frameworks and their interpretations on the development of novel herbal medical products. Such developments may not focus on medicine (drug) development as such, but the aim may also be to market these products as cosmetics, supplements, or even foods. Simplified procedures are commonly used for herbal medicinal products considered to be safe. For example, in India, “phytopharmaceuticals” can be registered based on simplified clinical trials.
In this Research Topic, the focus is on regulatory science and on what is needed in terms of R&D in this context. We encourage primary reports and reviews on the context of regulation and herbal medicine development, including:
• Pre-clinical studies and clinical trials on the activity in the context of registering/licensing a medicine of plant origin.
• Safety is often a hallmark of these research and development strategies, and, therefore, analysis of the implementation of such safety assessments will be welcome.
• Regulatory requirements for drug development from plant origin especially in the context of changing national legislations and on a comparative basis between countries and regions.
• Assessments of the evidence base required for such regulated products.
Topic Editor Dr Chandrakant Katiyar is the CEO of Emami Ltd (India). All other Topic Editors declare no competing interests with regards to the Research Topic subject.
---
All the manuscripts submitted to the collection will need to fully comply with the Four Pillars of Best Practice in Ethnopharmacology (you can freely download the full version here).
---
Keywords: Plant medicines, Phytopharmaceuticals, Clinical trial, Regulatory requirements
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.